Company Filing History:
Years Active: 1985-2003
Title: Innovations of Keith G McCullagh
Introduction
Keith G McCullagh is a notable inventor based in Princes Risborough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide cell modulators. With a total of 6 patents to his name, McCullagh's work has paved the way for advancements in therapeutic applications.
Latest Patents
One of his latest patents is focused on peptide linkers for covalent linking polypeptide cell modulators. This patent describes a new class of polypeptide cell modulators characterized by being composed of two covalently linked cell modulators in a linear polypeptide sequence. Such dual-function polypeptides exhibit new and particularly useful activities when the component polypeptide cell modulators are interferons, lymphokines, or cytotoxins. These components act through different and specific cell receptors to initiate complementary biological activities. Additionally, the patent describes a peptide linker segment comprising a mouse IgG gamma "hinge," in which the four cysteines of the "hinge" have been converted to serines.
Career Highlights
Throughout his career, McCullagh has worked with prominent companies in the biotechnology sector, including G.D. Searle & Company and Pharmacia Corporation. His experience in these organizations has contributed to his expertise in the development of innovative biopharmaceuticals.
Collaborations
Some of his notable coworkers include Leslie D Bell and Alan G Porter. Their collaborative efforts have further enhanced the research and development of polypeptide technologies.
Conclusion
Keith G McCullagh's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in therapeutic applications, showcasing the importance of innovation in science.